SERVIER (IRELAND) INDUSTRIES LIMITED

Servier (Ireland) Industries Limited is the Irish arm of the international, research-driven pharmaceutical group Servier. The company focuses on developing and delivering innovative medicines across three therapeutic areas - oncology, neurology and other high-impact health conditions - with a strong emphasis on patient-centred research. By collaborating closely with patients throughout the drug-development cycle, Servier aims to create therapies that not only advance scientific knowledge but also improve quality of life.

In addition to its core drug pipeline, Servier is expanding its research capacity through strategic partnerships and the launch of Servier Ventures, a dedicated venture-capital fund that backs breakthrough, high-risk innovations. Recent collaborations have brought promising treatments for rare genetic disorders and melanoma into the pipeline, while digital initiatives such as the DiamPark platform support Parkinson's patients with real-time, personalised tools.

Operating in Ireland, Servier works with healthcare providers, partners and local communities to ensure that its scientific progress translates into accessible, high-quality care for patients across the region.